Refine by
Surgery Infection Articles & Analysis
31 news found
Klebsiella is described by the Centers for Disease Control and Prevention (CDC) as a type of gram-negative bacteria that can cause different types of healthcare-associated infections (HAIs). These include pneumonia, bloodstream infections, wound or surgical site infections, and meningitis. Klebsiella are normally found in the human intestines (where they do not cause disease), and also in human ...
Introduction Intraoperative irrigation is a commonly used method aimed at reducing microbial burden by removing tissue debris, metabolic waste, and tissue exudate from the surgical field prior to site closure.1 With the absence of universally established standard of care and robust clinical data, the selection of appropriate irrigation solution remains a topic of debate. Isotonic saline has ...
The Centers for Disease Control and Prevention (CDC) describes Klebsiella as a type of gram-negative bacteria that can cause different types of healthcare-associated infections (HAIs). These include pneumonia, bloodstream infections, wound or surgical site infections, and meningitis. The agency warns Klebsiella bacteria have increasingly developed antimicrobial resistance, most recently to the ...
An article published last year in Emerging Infectious Diseases detailed a notable increase of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections in New York City during 2021 through June of 2022. The data for the study came from a large public healthcare system in New York City that serves more than 1.2 million people each year. The Centers for Disease Control and Prevention (CDC) ...
The IAQ Video Network and Cochrane & Associates announced the release of their latest educational video today. Their newest production discusses Klebsiella, a type of gram-negative bacteria that can cause various healthcare-associated infections (HAIs). “HAIs due to Klebsiella can include pneumonia, bloodstream infections, wound or surgical site infections, and meningitis,” said ...
Caresyntax, the leading vendor-neutral enterprise surgical data and intelligence platform designed to make surgery smarter and safer by converging AI-powered software, devices, and clinical services, today announced a partnership with ARC (Accelerate, Redesign, Collaborate) Sheba’s Global Innovation platform to establish and replicate the ARC Surgical Innovation Model using ...
Destiny Pharma attended the discussion and was very pleased that the meeting reinforced the Company’s conviction in infection prevention as a key component in the management of serious hospital-acquired infections. ...
After a detailed review, the Company has decided that the Phase 3 programme should consist of two Phase 3 studies including patients in two well-defined surgery models. One study will be in breast surgery as a model for general surgery and the other will be in expedited orthopedic surgery as a model of orthopedic ...
Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, is pleased to announce the commencement of an Investigational New Drug (IND) enabling safety study with its novel XF-73 Dermal formulation. This study is the second of two planned preclinical safety studies of the XF-73 ...
aureus is the primary pathogen associated with surgical site infections (SSIs).[i] No reportable adverse events. Ondine Biomedical Inc. ...
The Toronto-based research reports a decrease of viral infectivity of 90% of SARS-CoV-2 patient samples using Ondine’s nasal antimicrobial photodynamic disinfection (aPDT), with 70% of patient samples completely inactivated from a single 5-minute treatment. The nose is the primary location for SARS-CoV-2 entry and it has a central role in transmission and disease severity. The Journal ...
Recruited patients undergo a pre-surgery nasal culture to determine the prevalence of Staphylococcus aureus, the main cause of surgical site infections. ...
Combining capabilities to develop breakthrough technologies for transforming surgery. Hospitals and Surgery Centers face many challenges in surgery as they work to recover from COVID. Directors of Perioperative Services, Surgeons, OR Staff and OR managers are facing high levels of stress with maintaining quality patient care, increasing surgical case volume from backlogs, while at the same time ...
Imbed Biosciences Inc. (Imbed), a developer of next-generation therapies for tissue repair, and Spartan Medical, a veteran-owned Federal Contractor with fourteen years of flawless performance, jointly announced today that Imbed’s Microlyte® Matrix wound dressing portfolio has been added to Spartan Medical’s VA IDIQ Contract with the U.S. Department of Veteran Affairs (VA). The ...
Operating using Versius has enabled us to perform more keyhole surgery, allowing us to offer benefits such as faster recovery times, less time in hospital and reduced risk of infection to our patients.” At Policlinico di Milano, Versius will be used to perform a range of procedures including cholecystectomy, lower anterior resection and pulmonary resection ...
It can revolutionize, supplement and in some cases even replace conventional treatment methods in medical technology, e.g., in surgery to prevent infections in post-operative wounds. In nursing service, cold atmospheric plasma offers a therapeutic option to treat chronic and hard to heal wounds. ...
(Imbed), a privately held biotech company emerging as a leader in advanced wound care, announced today the results of a prospective clinical evaluation of its next-generation wound Matrix, Microlyte® SURGICAL, in diabetic patients undergoing foot and ankle surgery who would ordinarily be at risk of a surgical site infection. ...
Next Science Limited (ASX:NXS), an innovative medical technology company, announced that it will exhibit at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting and conference in San Diego, California, from Aug. 31 – Sept. 3. Next Science, whose mission is to heal patients and save lives by addressing the impact of biofilms on human health, will exhibit at Booth No. 5035. ...
Aatru has strategically targeted the Negative Pressure Wound Therapy (NPWT) for surgical incision market as there are 250MM annual surgeries globally, with approximately 53MM surgeries in the U.S. resulting in 500,000 surgical site infections ("SSIs") and 8,000 U.S. deaths. ...
TISSIUM is being recognized in the Surgery of the Future category with its project, “Innovative DrugEluting Adhesive for Surgery (IDEAS).” The project leverages TISSIUM’s unique adhesive drug delivery platform and seeks to address the shortcomings of CRS surgery, one of the most prevalent chronic illnesses in the US and EU, ...
ByTISSIUM